Zharikova A - Search Results

1

Intermittent high-dose ethanol exposures increase motivation for operant ethanol self-administration: possible neurochemical mechanism.

Li Z, Zharikova A, Vaughan CH, Bastian J, Zandy S, Esperon L, Axman E, Rowland NE, Peris J. Li Z, et al. Among authors: zharikova a. Brain Res. 2010 Jan 15;1310:142-53. doi: 10.1016/j.brainres.2009.11.029. Epub 2009 Nov 24. Brain Res. 2010. PMID: 19944084 Free PMC article.

2

Intermittent high-dose ethanol exposure increases ethanol preference in rats.

Peris J, Rhodes N, McCullough B, Aramini R, Zharikova A. Peris J, et al. Among authors: zharikova a. J Stud Alcohol Drugs. 2015 Jan;76(1):165-73. J Stud Alcohol Drugs. 2015. PMID: 25486406 Free PMC article.

3

Brain ethanol levels in rats after voluntary ethanol consumption using a sweetened gelatin vehicle.

Peris J, Zharikova A, Li Z, Lingis M, MacNeill M, Wu MT, Rowland NE. Peris J, et al. Among authors: zharikova a. Pharmacol Biochem Behav. 2006 Nov;85(3):562-8. doi: 10.1016/j.pbb.2006.10.010. Epub 2006 Nov 30. Pharmacol Biochem Behav. 2006. PMID: 17140644 Free PMC article.

4

Neuropharmacodynamic evaluation of the centrally active thyrotropin-releasing hormone analogue [Leu2]TRH and its chemical brain-targeting system.

Prokai L, Zharikova AD. Prokai L, et al. Brain Res. 2002 Oct 18;952(2):268-74. doi: 10.1016/s0006-8993(02)03251-1. Brain Res. 2002. PMID: 12376188

5

Proteomic analysis of the synaptic plasma membrane fraction isolated from rat forebrain.

Stevens SM Jr, Zharikova AD, Prokai L. Stevens SM Jr, et al. Brain Res Mol Brain Res. 2003 Oct 7;117(2):116-28. doi: 10.1016/s0169-328x(03)00282-1. Brain Res Mol Brain Res. 2003. PMID: 14559145

6

[Glu2]TRH dose-dependently attenuates TRH-evoked analeptic effect in mice.

Nguyen V, Zharikova AD, Prokai-Tatrai K, Prokai L. Nguyen V, et al. Brain Res Bull. 2010 Apr 29;82(1-2):83-6. doi: 10.1016/j.brainresbull.2010.02.007. Epub 2010 Feb 24. Brain Res Bull. 2010. PMID: 20188155 Free PMC article.

7

Integration of mass spectrometry into early-phase discovery and development of central nervous system agents.

Prokai L, Zharikova A, Janáky T, Li X, Braddy AC, Perjési P, Matveeva L, Powell DH, Prokai-Tatrai K. Prokai L, et al. Among authors: zharikova a. J Mass Spectrom. 2001 Nov;36(11):1211-9. doi: 10.1002/jms.227. J Mass Spectrom. 2001. PMID: 11747117

8

Centrally acting and metabolically stable thyrotropin-releasing hormone analogues by replacement of histidine with substituted pyridinium.

Prokai L, Prokai-Tatrai K, Zharikova AD, Nguyen V, Perjesi P, Stevens SM Jr. Prokai L, et al. J Med Chem. 2004 Nov 18;47(24):6025-33. doi: 10.1021/jm020531t. J Med Chem. 2004. PMID: 15537357

9

Cardiovascular effects of neuropeptide FF antagonists.

Prokai L, Zharikova AD, Juhasz A, Prokai-Tatrai K. Prokai L, et al. Among authors: zharikova ad. Peptides. 2006 May;27(5):1015-9. doi: 10.1016/j.peptides.2005.06.032. Epub 2006 Feb 21. Peptides. 2006. PMID: 16490281

10

Prodrugs to enhance central nervous system effects of the TRH-like peptide pGlu-Glu-Pro-NH2.

Prokai-Tatrai K, Nguyen V, Zharikova AD, Braddy AC, Stevens SM, Prokai L. Prokai-Tatrai K, et al. Bioorg Med Chem Lett. 2003 Mar 24;13(6):1011-4. doi: 10.1016/s0960-894x(03)00081-7. Bioorg Med Chem Lett. 2003. PMID: 12643900

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters